Opsens Inc. (TSE:OPS – Get Rating) – Research analysts at Raymond James dropped their FY2026 earnings per share estimates for shares of Opsens in a research note issued to investors on Thursday, July 14th. Raymond James analyst R. Sarugaser now forecasts that the company will post earnings of $0.09 per share for the year, down from their prior estimate of $0.10. The consensus estimate for Opsens' current full-year earnings is $0.02 per share.
Get Opsens alerts:Separately, Stifel Nicolaus assumed coverage on Opsens in a research report on Wednesday, April 13th. They set a "buy" rating and a C$3.35 price target for the company.
Opsens Trading Down 2.5 %
OPS opened at C$2.30 on Monday. The business has a 50 day simple moving average of C$2.10 and a two-hundred day simple moving average of C$2.09. The firm has a market capitalization of C$250.17 million and a price-to-earnings ratio of -38.98. The company has a debt-to-equity ratio of 14.63, a current ratio of 7.40 and a quick ratio of 6.26. Opsens has a one year low of C$1.55 and a one year high of C$3.74.About Opsens
(Get Rating)
Opsens Inc develops, manufactures, installs, and sells fiber optic sensors for interventional cardiology, fractional flow reserve (FFR), oil and gas, and industrial applications. The company operates in two segments, Medical and Industrial. The Medical segment primarily focuses on physiological measurement, such as FFR and dPR in the coronary artery stenosis market; and supplies a range of miniature optical sensors to measure pressure and temperature used in integrated applications in other medical devices, as well as licenses its optical sensor technology.
Recommended Stories
- Financial services firm Block stock has fallen (-59%) in 2022
- Hold Pfizer Today With Catalysts for Further Growth Tomorrow
- NVIDIA Stock is a Winding Up for a Record Setting Second Half
- Johnson & Johnson Continues to Prove its Value in a Volatile Year
- MarketBeat: Week in Review 7/11 – 7/15
Receive News & Ratings for Opsens Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Opsens and related companies with MarketBeat.com's FREE daily email newsletter.